Vaxfab enterprises announced the allotment of 34,39,136 equity shares through warrant conversion on January 26, 2026, marking a significant capital expansion for the Gujarat-based company. The Board of Directors approved the conversion at their meeting held on January 26, 2026, which commenced at 4:00 PM and concluded at 4:30 PM.

Share Allotment Details

The company allotted equity shares with the following specifications:

The equity shares were issued upon exercise of outstanding equity share warrants, which were originally issued through preferential allotment. The warrant exercise involved payment of Rs. 15.765 per warrant, as the initial Rs. 5.255 was paid at the time of warrant allotment.

Investor-wise Allocation

The warrant conversion was distributed among five investors as follows:

Correction of Earlier Errors

The company also addressed typographical errors in previous submissions dated January 12, 2026 and January 13, 2026. The corrections involved:

• Mr. Rakesh Shamji Patel: Corrected from 95,148 to 95,147 shares
• Mr. Sameet Khatri: Corrected from 118,997 to 118,934 shares
• Ms. Mita Hitesh Ajmera: Corrected from 237,874 to 237,869 shares

These corrections resulted in a change to the total number of shares allotted in the earlier tranches to 2,127,620 shares.

Impact on Share Capital

Following the warrant conversion, Vaxfab Enterprises' capital structure has been enhanced:

The newly allotted equity shares rank pari-passu in all respects with the existing equity shares of the company, ensuring equal rights and privileges for all shareholders.

Regulatory Compliance

The allotment was conducted in accordance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The warrant conversion was completed within the stipulated tenure of 18 months from the date of original warrant allotment, ensuring compliance with regulatory requirements. The company has informed both BSE Limited and The Calcutta Stock Exchange Limited about this development as part of its disclosure obligations.

Vaxfab Enterprises Limited has completed a substantial capital raising initiative through the allotment of fully convertible warrants and equity shares, marking a significant milestone in the company's expansion plans. The Board of Directors approved these allotments during their meeting held on January 12, 2026.

Warrant Allotment Details

The company has allotted 2,04,04,372 fully convertible warrants to 50 investors through preferential allotment. Each warrant is convertible into equivalent fully paid-up equity shares within a maximum period of 18 months from the allotment date.

The warrant allotment includes major allocations to entities such as Sparkling Tradewing LLP (19,98,097 warrants), Balmukund Tradelink Private Limited (19,74,310 warrants), and Markand Tradeventure LLP (19,55,281 warrants). Individual investors also participated significantly, with allocations ranging from 47,574 to 7,13,606 warrants per investor.

Equity Share Conversion

Simultaneously, the company issued 21,27,689 equity shares upon conversion of existing warrants by 41 investors. These shares were allotted at the same price of ₹21.02 per share, representing the exercise of previously allotted warrants.

Notable conversions include Mitesh Dineshbhai Patel and Seema Miteshkumar Patel, who each converted 3,09,229 warrants, and Mita Hitesh Ajmera, who converted 2,37,874 warrants into equity shares.

Impact on Share Capital

Following these allotments, Vaxfab Enterprises' paid-up equity share capital has increased substantially. The company's capital structure has been strengthened through this fundraising exercise.

Regulatory Compliance and Corrections

The company also addressed typographical errors from its previous submission dated January 12, 2026. The corrected figures show 2,04,04,372 warrants allotted instead of the previously mentioned 2,04,04,371, and Ms. Hema Hardik Parikh's allocation was corrected to 1,90,294 warrants instead of 2,85,442.

All allotments comply with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The equity shares allotted upon warrant conversion rank pari-passu with existing equity shares of the company. The Board meeting commenced at 8:00 PM and concluded at 8:30 PM on January 12, 2026, with Managing Director Ravindra Ashokbhai Joshi overseeing the proceedings.